• Heparin sodium as a Nanovesicle Assay Variable

  2026-08-18

  Heparin sodium is more than a glycosaminoglycan anticoagulant: in nanovesicle experiments, it can become an important experimental variable when heparan sulfate proteoglycans mediate cellular uptake. This article translates recent Sertoli-cell findings into practical assay controls, endpoint selection, and research-use considerations for A5066.

• Amitriptyline HCl in BBB Permeability Workflows

  2026-08-18

  Amitriptyline HCl can serve as a mechanistically informative challenge compound for linking receptor pharmacology with blood-brain barrier transport. This workflow combines bidirectional LLC-PK1-MOCK/MDR1 assays, recovery analysis, and lysosomal-trapping controls to distinguish exposure from apparent permeability.

• SERCA-ER Stress Drives HSC Mobilization

  2026-08-17

  Li et al. show that pharmacological SERCA inhibition with BHQ induces mild endoplasmic reticulum stress and enhances hematopoietic stem cell mobilization in mice. The study connects calcium homeostasis disruption to the CaMKII–STAT3–CXCR4 axis, providing a mechanistic framework for improving stem cell collection while highlighting important preclinical limitations.

• Afatinib in Gastric Cancer Assembloid Research

  2026-08-17

  Afatinib, also known as BIBW 2992, enables controlled interrogation of ErbB-driven signaling in patient-derived gastric cancer organoids and assembloids. This workflow shows how matched stromal cells can reveal microenvironment-dependent drug resistance that conventional monocultures may miss.

• Merimepodib (VX-497): A Metabolic Assay Playbook

  2026-08-16

  Merimepodib (VX-497) is a selective IMPDH inhibitor that reveals how guanine nucleotide supply shapes lymphocyte and viral phenotypes. This assay-centered guide explains how to distinguish pathway-specific effects from nonspecific cytotoxicity, using new PEDV findings to refine experimental design.

• EdU Imaging Kits (Cy3) for CAF Organoid Assays

  2026-08-15

  EdU Imaging Kits (Cy3) make S-phase DNA synthesis visible in complex breast cancer organoid–CAF models without DNA denaturation. This workflow helps separate treatment-related proliferation changes from the stromal protection described in patient-derived hybrid organoids.

• HyperTrap Heparin HP Column: Workflow Guide

  2026-08-14

  The HyperTrap Heparin HP Column uses HyperChrom Heparin HP Agarose for ready-to-use affinity purification of heparin-binding biomolecules. Its 34 μm matrix, broad pH tolerance, and flexible format support high-resolution research workflows, while the CCR7–Notch1 study provides biological context rather than direct validation of this column.

• Chloroquine Diphosphate in Autophagy–Ferroptosis Assays

  2026-08-14

  Chloroquine Diphosphate can do more than label an autophagy experiment: it helps separate lysosomal flux effects from therapy-induced cell death. This article integrates A8628 product chemistry with a cetuximab-resistance study to improve assay interpretation in cancer research.

• Cy5 amine (non-sulfonated): Labeling Guide

  2026-08-13

  Cy5 amine (non-sulfonated) is a primary-amine cyanine reagent for covalent labeling through activated esters, carbodiimide-activated carboxyl groups, or epoxides. Its water insolubility requires preparation in DMSO or ethanol before transfer into a compatible aqueous labeling workflow; it is intended for research use and not for diagnostic or medical applications.

• EdU Imaging Kits (Cy3) for S-Phase Analysis

  2026-08-13

  EdU Imaging Kits (Cy3) use 5-ethynyl-2'-deoxyuridine and CuAAC chemistry to detect DNA synthesis without antibody-based DNA denaturation. The method provides a practical fluorescence microscopy cell proliferation assay for linking S-phase activity with cancer biology and genotoxicity testing.

• CCK-8 for Senescent-Cell Metabolism Studies

  2026-08-12

  Discover how cck8 chemistry can clarify cell viability measurement in senescent-cell and implant research. This guide connects Cell Counting Kit-8 data with metabolic interpretation, assay controls, and the directed rescue strategy reported in aged-rat osteointegration research.

• Heparin sodium in Nanovesicle Uptake Assays

  2026-08-12

  Heparin sodium provides a practical dual-use reagent: a defined anticoagulant benchmark for thrombosis workflows and a hypothesis-testing probe for heparan sulfate proteoglycan-mediated nanovesicle uptake. This article translates findings from a Cistanche deserticola nanovesicle study into executable assay design, controls, and troubleshooting steps.

• ARB Reprograms Armored and Cold Tumors

  2026-08-11

  The reference study identifies AGTR1 as a stromal vulnerability in collagen-rich, immune-excluded tumors and shows that angiotensin receptor blockade can remodel the tumor microenvironment. Its findings connect cancer-associated fibroblast signaling, extracellular-matrix deposition, and improved immune checkpoint blockade response across experimental and clinical datasets.

• AT13387 Hsp90 Inhibitor Workflows for Cancer Research

  2026-08-11

  AT13387 enables mechanism-led Hsp90 chaperone inhibition studies that connect client-protein loss with cell cycle arrest and apoptosis induction. This guide translates its formulation, potency, and tumor-retention attributes into reproducible cancer biology research workflows while carefully distinguishing established evidence from cross-domain assay ideas.

• PEDV Replication Depends on IMPDH-Driven Nucleotide Synthesi

  2026-08-10

  The reference study identifies IMPDH-dependent guanine nucleotide biosynthesis as a host metabolic requirement for porcine epidemic diarrhea virus replication. By combining comparative metabolomics with IMPDH2 knockdown and Merimepodib (VX-497) treatment, the authors provide convergent evidence for a host-directed antiviral strategy while also highlighting cell-type-specific metabolic responses.

16775 records 1/1119 page Next 12345 下5页 Last page